Categories
Case Study

Taking Shared Services to a New Level at a Healthcare Company

We conducted a four-week diagnostic that identified opportunities to not only cut costs significantly, but dramatically improve patient experiences.

Four years after its launch, HospitalCo’s SSC had outgrown its original design. Problems included contested resources and informal service-level agreements. Meanwhile, HospitalCo faced significant headwinds from competition, tough negotiations with health funds, and a customer base turning away from private health insurance markets. Customers lacked awareness of its services, and managers encountered resistance to change from hospitals that were reluctant to cede control.

We mapped HospitalCo’s processes across functions and subfunctions, using interviews with management as well as benchmarking and digital-maturity assessments. Our approach also brought the voice of HospitalCo’s customers into the evaluations, through interviews and benchmarking of the customer experience.

Categories
Case Study

How a Pharmaceutical Services Company Mastered the Art of Value Pricing

Having developed a new solution that was significantly more efficient than the next-best product available, a pharma services company was on the verge of doing what companies do all too often: apply a conventional pricing approach to a new innovation, thus missing a golden opportunity to realize more value.

We worked with the company to redress that situation by applying our comprehensive six-step approach to value pricing innovation. As a result, PharmaCo* was able to identify opportunities to increase launch revenue by 50% over three years.

Categories
Digital Transformation

Scaling Your Digital Transformation

Don’t be fooled by the term “digital transformation.” The profound changes that business leaders live with day in and day out are made possible by digital technology. But just as important are the surprising and unexpected ways that people interact with technology. Recognizing that provides clarity and focus, and highlights the need to get technologists and experts with deep customer empathy in the same room, working on the same problems. Digital transformation is technology and people, innovation and disruption, offense and defense in equal measures.

Look, for example, at the rapid global spread of ride hailing. Digital technology made it possible for Uber and Didi Chuxing to match riders with drivers efficiently, inexpensively and on a massive scale. But it was customers’ embrace of the service, their willingness to jump into the cars of total strangers, that enabled those companies to redefine transportation. Similarly, Airbnb wouldn’t have been valued at $31 billion just nine years after its founding if customers hadn’t quickly become comfortable sleeping in someone else’s bed. In retail, the willingness of consumers to trust the product reviews of 1,000 online strangers, and write paragraphs of detailed description of their own, moved e-commerce from a digitized catalog to a true substitute for the trusted shop owner.

For business leaders, part of the challenge lies in the fact that the 10 to 15 major enabling technologies are very different from one another—Internet of Things, artificial intelligence, augmented reality, each has different applications and impact across different sectors of the economy. That adds complexity and fuels some of the frustration at the top of companies. It also creates real risks of many false starts and half measures chasing after “disruption,” especially because there’s no comprehensive playbook for building a digital enterprise.

Categories
Digital Transformation

A Step-by-Step Guide to Digital Transformation

Transforming a company into a digital enterprise is tough. Many companies have had some success, but few have completed this metamorphosis. No comprehensive playbook, or even checklist, exists for executives to follow.

A prudent first step is to learn from others—both inside and outside our industries. This brought us in late November to a meeting of more than 20 executives from a range of industries from across the world, hosted by the World Economic Forum.

Our ambition: to explore the challenges raised by digital transformation, design answers, and create practical tools on how to transform a company with digital.

Categories
Healthcare

Asia-Pacific Telemedicine Platforms Will Long Outlast Covid-19

The Covid-19 pandemic sparked a dramatic acceleration in the adoption of digital health tools throughout Asia, rapidly transforming consumer behavior. Today, as governments lift restrictions and patients become more comfortable with in-person doctor’s appointments, telemedicine usage has remained resilient. At MyDoc, a telemedicine platform headquartered in Singapore, the number of monthly active users grew 272% from January 2019 to January 2021. Registered users also rose 65% year over year. Similarly, Chinese digital health platform Ping An Good Doctor saw an 18% increase in newly registered users and a 24% increase in daily consultations in 2020 compared with 2019. While usage has declined from its pandemic peak, it is evident that telemedicine is here to stay.

As physicians drastically reduced primary care visits, telemedicine platforms quickly became the first touchpoint on the patient journey. Physicians can treat a majority of teleconsultation cases virtually. MyDoc, for instance, manages or resolves nearly 78% of cases on the platform. For the remaining cases, telemedicine serves as a point of triage to in-person services, across general practitioners, specialists, accident and emergency clinics, and more. In steering patients through the healthcare system, telemedicine is improving patient outcomes, reducing patient and payer costs, and alleviating the burden of overcrowded hospitals to make healthcare systems more efficient. Leading payers and providers will continue to incorporate telemedicine services into their core offerings to enhance the patient experience and optimize resources.  

Categories
Healthcare

Pharma’s Pandemic Fallout: US Drug Shortages

Covid-19 severely disrupted pharmaceutical supply chains, issuing a loud warning to the industry: Far-flung manufacturing sites carry a perilous risk. But the pandemic wasn’t the first alarm. While the transfer of pharma sourcing and manufacturing to Asia has lowered costs, it has also directly affected supply chain reliability. Data from the US Food and Drug Administration (FDA) shows an increase in prepandemic drug shortages resulting from several factors, including quality issues and disruptive events, such as the 2017 fire at a Chinese plant that led to a global shortage of piperacillin/tazobactam.

The winner-take-all generic pharmaceutical bidding process in Germany also has produced drug shortages by reducing the number of producers or bidders over time. In some cases, for example, the winners were sales offices dependent on foreign third-party manufacturers incapable of delivering high drug volumes.

Categories
Healthcare

Healthcare as National Defense

The public-private partnerships forged in the heat of Covid-19 could change our very conception of what’s possible in healthcare.

In part two of our healthcare series we’ll consider how Covid ushered in a concept that has enormous implications for investors: healthcare as national defense.

“This notion of healthcare as national defense took hold when our country realized we didn’t have enough ventilators and PPE at the beginning of the pandemic, and we didn’t have a local supply chain to be able to secure it,” Nirad Jain says.

The partnerships that formed between the public and private sectors will not only outlast Covid, they could remove what once seemed like immovable obstacles to drug development, IT investments, payment processing, and home care.

Categories
Healthcare

How the NHS Waiting List Crisis Can Accelerate the Reimagining of Care

A micro-battle mindset and Win-Scale-Amplify approach can enable healthcare providers to recover the backlog and transform productivity through innovation.